| Mary Whittemore, MD, MPH | |
|
540 Belvedere Blvd Ste 100, Charlottesville, VA 22901-3215 | |
| (434) 654-2830 | |
| (833) 232-3632 |
| Full Name | Mary Whittemore |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 540 Belvedere Blvd Ste 100, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023452562 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101260888 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ivyrehab Sept, Llc | 7911990908 | 1137 |
News Archive
C2N Diagnostics and AbbVie today announced that the U.S. Food and Drug Administration has granted their investigational recombinant humanized anti-tau antibody, C2N-8E12 (ABBV-8E12), an orphan drug designation for the treatment of progressive supranuclear palsy (PSP).
A multi-center research project to investigate severe asthma has found a key physiological difference between severe and non-severe forms of the disease, a finding that could help explain why those with severe asthma do not respond well to treatment.
Nanorods made of bismuth sulfide kill tumor cells with heat when they are irradiated with near-infrared light. Chinese scientists are now making these weapons more powerful by remodeling the defect state of the nanorod crystal lattice by adding gold nanodots.
As soon as they have grown to pinhead size, tumors rely on the formation of new blood vessels - a process which is scientifically called angiogenesis. Interfering with this process (antiangiogenesis) is considered to be a promising approach in cancer medicine. However, those drugs that are already available for preventing the sprouting of new blood capillaries have failed to fulfill the high expectations placed on them.
Explosive advancement in human genome sequencing opens new possibilities for identifying the genetic roots of certain diseases and finding cures. However, so many variations among individual genomes exist that identifying mutations responsible for a specific disease has in many cases proven an insurmountable challenge.
› Verified 3 days ago
| Entity Name | Martha Jefferson Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275720559 PECOS PAC ID: 5991889081 Enrollment ID: O20080228000055 |
News Archive
C2N Diagnostics and AbbVie today announced that the U.S. Food and Drug Administration has granted their investigational recombinant humanized anti-tau antibody, C2N-8E12 (ABBV-8E12), an orphan drug designation for the treatment of progressive supranuclear palsy (PSP).
A multi-center research project to investigate severe asthma has found a key physiological difference between severe and non-severe forms of the disease, a finding that could help explain why those with severe asthma do not respond well to treatment.
Nanorods made of bismuth sulfide kill tumor cells with heat when they are irradiated with near-infrared light. Chinese scientists are now making these weapons more powerful by remodeling the defect state of the nanorod crystal lattice by adding gold nanodots.
As soon as they have grown to pinhead size, tumors rely on the formation of new blood vessels - a process which is scientifically called angiogenesis. Interfering with this process (antiangiogenesis) is considered to be a promising approach in cancer medicine. However, those drugs that are already available for preventing the sprouting of new blood capillaries have failed to fulfill the high expectations placed on them.
Explosive advancement in human genome sequencing opens new possibilities for identifying the genetic roots of certain diseases and finding cures. However, so many variations among individual genomes exist that identifying mutations responsible for a specific disease has in many cases proven an insurmountable challenge.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Whittemore, MD, MPH Po Box 79777, Baltimore, MD 21279-0777 Ph: (434) 654-7794 | Mary Whittemore, MD, MPH 540 Belvedere Blvd Ste 100, Charlottesville, VA 22901-3215 Ph: (434) 654-2830 |
News Archive
C2N Diagnostics and AbbVie today announced that the U.S. Food and Drug Administration has granted their investigational recombinant humanized anti-tau antibody, C2N-8E12 (ABBV-8E12), an orphan drug designation for the treatment of progressive supranuclear palsy (PSP).
A multi-center research project to investigate severe asthma has found a key physiological difference between severe and non-severe forms of the disease, a finding that could help explain why those with severe asthma do not respond well to treatment.
Nanorods made of bismuth sulfide kill tumor cells with heat when they are irradiated with near-infrared light. Chinese scientists are now making these weapons more powerful by remodeling the defect state of the nanorod crystal lattice by adding gold nanodots.
As soon as they have grown to pinhead size, tumors rely on the formation of new blood vessels - a process which is scientifically called angiogenesis. Interfering with this process (antiangiogenesis) is considered to be a promising approach in cancer medicine. However, those drugs that are already available for preventing the sprouting of new blood capillaries have failed to fulfill the high expectations placed on them.
Explosive advancement in human genome sequencing opens new possibilities for identifying the genetic roots of certain diseases and finding cures. However, so many variations among individual genomes exist that identifying mutations responsible for a specific disease has in many cases proven an insurmountable challenge.
› Verified 3 days ago
Kevin Arthur Volkema, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 10th St Ne, Charlottesville, VA 22902 Phone: 434-654-1950 Fax: 434-977-9808 | |
Miss Holly A Johnson, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1244 Clifden Greene, Charlottesville, VA 22901 Phone: 434-975-0243 | |
Timothy E. Mclaughlin, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 375 Four Leaf Ln Ste 103, Charlottesville, VA 22903 Phone: 434-243-0700 Fax: 434-244-0680 | |
Malinda L Whitlow, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 1222 Jefferson Park Ave, Charlottesville, VA 22903 Phone: 434-982-3040 Fax: 434-245-3535 | |
Michael R. Harper, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1800 Timberwood Blvd, Charlottesville, VA 22911 Phone: 434-975-7700 Fax: 434-975-7724 | |
Arjun Muthusubramanian, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 260 Pantops Ctr, Charlottesville, VA 22911 Phone: 434-244-3027 |